argenx SE
pemphigus serves as proof of concept for blistering diseases | argenx SE
Company
Deck Type
Sector
Industry
Deck date
July 2021
Slide
44 of 69
Related slides by other companies
GreenLight
SPAC
August 2021
developing proof of concept for novel based approach to gene therapy | GreenLight
D-Wave
Investor Day
January 2024
energies quantum computing proof of concept | D-Wave
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights